112 related articles for article (PubMed ID: 18599346)
1. Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction.
Stumpf C; Seybold K; Petzi S; Wasmeier G; Raaz D; Yilmaz A; Anger T; Daniel WG; Garlichs CD
Eur J Heart Fail; 2008 Aug; 10(8):733-9. PubMed ID: 18599346
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
3. Qiliqiangxin regulates the balance between tumor necrosis factor-alpha and interleukin-10 and improves cardiac function in rats with myocardial infarction.
Xiao H; Song Y; Li Y; Liao YH; Chen J
Cell Immunol; 2009; 260(1):51-5. PubMed ID: 19833326
[TBL] [Abstract][Full Text] [Related]
4. Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats.
Batista ML; Rosa JC; Lopes RD; Lira FS; Martins E; Yamashita AS; Brum PC; Lancha AH; Lopes AC; Seelaender M
Cytokine; 2010 Jan; 49(1):102-8. PubMed ID: 19948415
[TBL] [Abstract][Full Text] [Related]
5. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy.
Koch M; Savvatis K; Scheeler M; Dhayat S; Bonaventura K; Pohl T; Riad A; Bulfone-Paus S; Schultheiss HP; Tschöpe C
Int Immunopharmacol; 2010 Feb; 10(2):207-12. PubMed ID: 19897056
[TBL] [Abstract][Full Text] [Related]
7. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects.
Bauersachs J; Hiss K; Fraccarollo D; Laufs U; Ruetten H
Cardiovasc Res; 2006 Dec; 72(3):438-46. PubMed ID: 17026973
[TBL] [Abstract][Full Text] [Related]
10. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
11. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.
Rong SL; Wang YJ; Wang XL; Lu YX; Chang C; Wang FZ; Liu QY; Liu XY; Gao YZ; Mi SH
Chin Med J (Engl); 2009 Oct; 122(19):2352-9. PubMed ID: 20079139
[TBL] [Abstract][Full Text] [Related]
13. Heart function and molecular biological parameters are comparable in young adult and aged rats after chronic myocardial infarction.
Deten A; Marx G; Briest W; Christian Volz H; Zimmer HG
Cardiovasc Res; 2005 May; 66(2):364-73. PubMed ID: 15820205
[TBL] [Abstract][Full Text] [Related]
14. [Effects of early treatment with metoprolol on myocardial inflammatory cytokine expression and heart function in rats with acute myocardial infarction].
Cheng X; Liao YH; Li B; Yang YL; Zhang JY; Lu BJ; Ge HX; Liu Y; Guo ZQ; Zhang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):448-52. PubMed ID: 15932707
[TBL] [Abstract][Full Text] [Related]
15. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
16. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
Xu K; George I; Klotz S; Hay I; Xydas S; Zhang G; Cerami A; Wang J
J Cardiovasc Pharmacol; 2010 Nov; 56(5):506-12. PubMed ID: 20881614
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect.
Huang CX; Yuan MJ; Huang H; Wu G; Liu Y; Yu SB; Li HT; Wang T
Peptides; 2009 Dec; 30(12):2286-91. PubMed ID: 19747956
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
[TBL] [Abstract][Full Text] [Related]
20. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
